MaxWell Biosystems provides next generation high-content electrophysiology platforms to facilitate detailed investigation of cells in vitro. MaxOne and MaxTwo are microelectrode array systems ideally suited to phenotype human iPSC-derived neuronal disease models and screen pharmacological compounds. A high electrode density and high signal-to-noise ratio ensure that every single cell can be captured and analyzed, providing detailed insights into neuronal network functionality and maturity.
Location: Switzerland, Zurich
Employees: 11-50
Total raised: $4.52M
Founded date: 2016
Investors 3
| Date | Name | Website |
| - | The Techno... | technology... |
| - | Venture Ki... | venturekic... |
| 08.08.2023 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.12.2020 | Series A | $4.52M | - |
Mentions in press and media 20
| Date | Title | Description |
| 01.07.2025 | Maxwell Biosystems and 8inks on an international growth course | Maxwell Biosystems is a Zurich-based startup providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic ce... |
| 11.03.2024 | Promising new tool for uncovering key characteristics of neurodegenerative diseases | Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems provides high-density microelectrode array (HD-MEAs) technology, an electrophysiological platform for recording and stimulating electrogenic cells in vitro, in a singl... |
| 10.12.2021 | Loan guarantees for five startups | |
| 17.12.2020 | MaxWell Biosystems obtains CHF 4 million in Series A financing round | MaxWell Biosystems AG, founded in 2016, provides high-content electrophysiology platforms that advance scientific discovery and accelerate drug discovery for neurodegenerative diseases. Its first product, MaxOne, is a high-density microelec... |
| 17.12.2020 | MaxWell Biosystems obtains CHF 4 million in Series A financing round | |
| 16.12.2020 | MaxWell Biosystems Completes CHF 4 million Series A Financing Round to further industrialize and scale-up | MaxWell Biosystems, a spin-off from ETH Zürich, develops and commercializes cell imaging systems that empower scientists in pharma and academia to reveal the function of neuronal networks in a dish. With these systems, users can accelerate ... |
| 04.09.2020 | Finalisten des Entrepreneur Of The Year stehen fest | 60 Schweizer Unternehmer haben sich 2020 dem Wettbewerb gestellt. Die elfköpfige Jury des EY Entrepreneur Of The Year, der neben Corporate-Vertretern auch ehemalige Gründer wie Thomas Hanan (Webrepublic) und Jan Lichtenberg (InSphero) angeh... |
| 04.09.2020 | Finalisten des Entrepreneur Of The Year stehen fest | |
| 09.05.2019 | University of Basel Innovation and Startup exploration mission to Korea | |
| 28.12.2018 | 20 Swiss startup projects supported by the EU SME Instrument |
Show more